About Index Trending news
Analyze
Pricing
BIND Therapeutics

BIND Therapeutics

Work at BIND Therapeutics? Add yourself to this profile

BIND Therapeutics

BIND Therapeutics is a clinical-stage nanomedicine platform company developing Accurins, a class of highly selective, targeted therapeutics.
Edit Profile
More info

Elsewhere

Also headquartered in Cambridge

MIT MIT Raspberry Pi Raspberry Pi ARM ARM Xconomy Xconomy Mobile.co Mobile.co HubSpot HubSpot nuTonomy nuTonomy Biogen Biogen General Catalyst General Catalyst Harvard University Harvard University

Companies in the same industry

Empire Genomics Empire Genomics Impedans Impedans Micar21 Micar21 Prospective Research Prospective Research MyGeneCounsel MyGeneCounsel iCarbonX iCarbonX Avita Medical Avita Medical NanoCellect Biomedical, Inc. NanoCellect Biomedical, Inc. Motus Therapeutics Motus Therapeutics Euclises Pharmaceuticals Euclises Pharmaceuticals

Alexa global traffic share

Twitter followers

Terms of Service API Integrations Plans & Pricing
Built with ❤︎ by Datalicious ©2017
A daughter company of TNW.
Index.co is not affiliated with Index Ventures.

Overview

Funding 2
Add info
13 Feb 2012
$25,500,000
Venture capital (Series D)
RUSNANO
29 Jun 2010
$12,400,000
Venture capital (Series C)
Endeavour Vision, Flagship Ventures, Polaris Partners, +2